Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS
Clinical trial NCT04681118 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04681118
- Sponsor
- Brainstorm-Cell Therapeutics
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.